Featured

Week in Review

Week in Review

The Supreme Court holds oral arguments in Loper Bright Enterprises v. Raimondo, agrees to hear homeless encampments case, and more…

The Telehealth of Tomorrow

The Telehealth of Tomorrow

Scholar calls on Congress to expand telehealth services in rural parts of the United States.

Uncovering Private Lawyers’ Role in Whistleblower Programs

Uncovering Private Lawyers’ Role in Whistleblower Programs

Scholar argues that private lawyers’ involvement in whistleblower programs poses efficiency, fairness, and accountability concerns.

A Role for Antitrust in Online Content Moderation

A Role for Antitrust in Online Content Moderation

Scholar argues that updates to antitrust regulation could support healthy online discourse.

Is It Time to End Animal Testing?

Is It Time to End Animal Testing?

Scholars recommend regulators promote alternatives to experiments conducted on animals.

Week in Review

Week in Review

The SEC approves bitcoin ETFs, EPA prohibits the manufacture of certain PFAS, and more…

Rethinking Firearms Regulation

Rethinking Firearms Regulation

Scholar argues that guns should be regulated as consumer products.

FDA’s Minimal Authority over Dietary Supplements

FDA’s Minimal Authority over Dietary Supplements

Scholars urge Congress to give FDA more power to regulate dietary supplements.

Examining the New Artificial Intelligence Executive Order

Examining the New Artificial Intelligence Executive Order

President Biden issues an executive order directing federal agencies to regulate emerging AI technologies.

Lingering Questions About the Major Questions Doctrine

Lingering Questions About the Major Questions Doctrine

Scholars discuss the origins, scope, and merits of the U.S. Supreme Court’s “major questions doctrine.”

Week in Review

Week in Review

The Fifth Circuit rules that Texas hospitals are not required to follow HHS abortion guidance, the Ninth Circuit allows California to restrict public gun possession, and more…

Enron Revisited

Enron Revisited

Scholar argues that regulatory action should reflect underlying causes of corporate fraud.